Natrium-4-aminosalicylat

Aminosalicylate sodium anhydrous

HCID 2724368CAS 133-10-8

Grundinformationen

Standard-SMILES
Nc1ccc(C(=O)[O-])c(O)c1.[Na+]
InChIKey
FVVDKUPCWXUVNP-UHFFFAOYSA-M
Summenformel
C7H6NNaO3
Durchschnittliche Molmasse
175,12 g/mol
Monoisotopische Masse
175,02453734

Namen und Bezeichner

Bevorzugter Name
Aminosalicylate sodium anhydrous
IUPAC
sodium 4-amino-2-hydroxybenzoate
Lokaler Name
Natrium-4-aminosalicylat
Englischer Name
Sodium 4-aminosalicylate
Summenformel
C7H7NO3.Na
Molmasse
176.13

Namen und Synonyme

Sodium 4-aminosalicylatep-Aminosalicylic acid sodium saltp-Aminosalicylate sodiumAminosalicylate sodium anhydrousDTXSID0046066T9ZKL3TNQF4-aminosalicylate sodiumDTXCID8026066RefChem:1076657205-091-2133-10-8sodium 4-amino-2-hydroxybenzoate
Weitere Namen anzeigen
nippaspasadepas-napasnalsalvissodiopassodiumpas
Sodium p-aminosalicylateSodium PASBactylanSanipirolTubersanLepasen8031-28-54-AMINOSALICYLIC ACID SODIUM SALT

Datenbank-Bezeichner

CAS
133-10-8
PubChem CID
2724368
DTXSID
DTXSID0046066
ChEBI
CHEBI:2661
UNII
T9ZKL3TNQF
EC Number
205-091-2

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA)
86,4 Ų
H-Brücken-Donoren
2
H-Brücken-Akzeptoren
4
Frei drehbare Bindungen
1
Schwere Atome
12

Physikochemische Eigenschaften

Schmelzpunkt
265 · 265-270 °C
storage temp.
Sealed in dry,Room Temperature
Aggregatzustand
crystalline
Farbe
white
CAS Datenbank
133 · 133-10-8(CAS DataBase Reference)
EPA chemische Informationen
4 · Benzoic acid, 4-amino-2-hydroxy-, monosodium salt (133-10-8)

Sicherheit und Regulatorisches

GHS-Klassifizierung

GHS Classification · 6 Einträge

This chemical does not meet GHS hazard criteria for 54.5% (6 of 11) of all reports.

Warning

H315 (45.5%): Causes skin irritation [Warning Skin corrosion/irritation];H319 (45.5%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H335 (36.4%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]

P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 11 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Reported as not meeting GHS hazard criteria per 6 of 11 reports by companies.;There are 5 notifications provided by 5 of 11 reports by companies with hazard statement code(s).;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

Gefahrenhinweise

Hazard Classes and CategoriesSkin Irrit. 2 (45.5%);Eye Irrit. 2 (45.5%);STOT SE 3 (36.4%)

Sicherheitsdaten

wgk
3
tsca
TSCA listed
RTECS-Nr.
VO1700000
risk_code
36/37/38
hazard_code
Xi
safety_code
26-36

Chemie und Industrie

Pharmakologische Informationen

ATC CodeJ04AA01

Verwendung und Herstellung

General Manufacturing InformationBenzoic acid, 4-amino-2-hydroxy-, sodium salt (1:1): INACTIVE

Vor- und nachgelagerte Produkte

Anbieter50 Anbieter

湖北威德利化学试剂有限公司181-6332-1995 18062128043 · [email protected]
武汉鹏垒生物科技有限公司15871464247 · [email protected]
武汉欣扬瑞和化学科技有限公司13720274133 · [email protected]
上海哲研生物科技有限公司021-18017610038 18017610038 · [email protected]
湖北海克斯生化有限公司17362916295; 17362916295 · [email protected]

Zugehörige Reaktionen

4

Verknüpfte Notizen

Wird geladen…